|
WHO IRIS >
Browsing by Subject Drug and Narcotic Control
Showing results 266 to 285 of 355
| Issue Date | Title | Author(s) | Document no. | | 2003 | SACTob principes directeurs pour l' évaluation des produits du tabac nouveaux ou modifiés / Comité Consultatif Scientifique sur la Réglementation des Produits du Tabac | WHO Scientific Advisory Committee on Tobacco Product Regulation; WHO Tobacco Free Initiative | - |
| 2003 | SACTob statement of principles guiding the evaluation of new or modified tobacco products / Scientific Advisory Committee on Tobacco Product Regulation (SACTob) | WHO Scientific Advisory Committee on Tobacco Product Regulation; WHO Tobacco Free Initiative | - |
| 1996 | Safety issues : drug safety monitoring centres | - | - |
| 1997 | Sale of medical products through the Internet : general policy issues | - | - |
| 1983 | Septième examen des substances psychotropes relatif à leur contrôle international: Genève, 7-11 mars 1983 | World Health Organization | MNH/83.7 |
| 1995 | Servicio nacional de control : directrices para la evaluaci'on de la calidad de las vacunas en pa'ises no productores | World Health Organization. Vaccine Supply and Quality Unit | WHO/VSQ/95.1. Unpublished |
| 1983 | Seventh review of psychoactive substances for international control : Geneva, 7-11 March 1983 | World Health Organization | MNH/83.7 |
| 2005 | Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS / a joint UNICEF, UNAIDS Secretariat, WHO, MSF project | UNICEF; UNAIDS; World Health Organization. Dept. of Essential Drugs and Medicines Policy; Médecins sans frontières (Association) | - |
| 2004 | Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS / a joint UNICEF, UNAIDS Secretariat, WHO, MSF project | UNICEF; UNAIDS; World Health Organization. Dept. of Essential Drugs and Medicines Policy; Médicins sans Frontières | WHO/EDM/PAR/2004.4 |
| 1980 | Study on guidelines for the exemption of preparations under Article 3 of the Convention on Psychotropic Substances, 1971 / by Erik Widerlöv and Tommy Lewander | Widerlöv, Erik; Lewander, Tommy; World Health Organization. Division of Mental Health | MNH/80.1. Unpublished |
| 1991 | Study on the impact of scheduling benzodiazepines | World Health Organization. Programme on Substance Abuse | WHO/PSA/91.3. Unpublished |
| 2005 | Substances psychoactives engendrant : une dépendance : directives supplémentaires : rapport du Secrétariat | Conseil exécutif, 115 | EB115/12 |
| 2004 | Substances psychoactives engendrant une dépendance : directives supplémentaires : rapport du Secrétariat | Conseil exécutif, 114 | EB114/7 |
| 1998 | Suivi et évaluation des politiques pharmaceutiques nationales et mesure des effets du travail de DAP : thème de discussions approfondies | WHO Action Programme on Essential Drugs | DAP/MAC(10)/98.6 |
| 2004 | Sustancias psicoactivas causantes de dependencia: orientaciones suplementarias: informe de la Secretaría | Consejo Ejecutivo, 114 | EB114/7 |
| 2005 | Sustancias psicoactivas causantes de dependencia: orientaciones suplementarias: informe de la Secretaría | Consejo Ejecutivo, 115 | EB115/12 |
| 1998 | Technical and health matters : revised guidelines for the WHO review of dependence-producing psychoactive substances for international control : report by the Secretariat | World Health Organization Executive Board Session. (103rd : 1999 : Geneva, Switzerland) | EB103/24 |
| 1999 | Technical and health matters: revised guidelines for the WHO review of dependence-producing psychoactive substances for international control: report by the Secretariat | Executive Board, 103 | EB103/24 |
| 2001 | Tercer informe de la Comisión A: (proyecto) | Asamblea Mundial de la Salud, 54 | (Proyecto) A54/48 |
| 2001 | Third report of Committee A: (draft) | World Health Assembly, 54 | A54/48 |
Showing results 266 to 285 of 355
|
